2026
Development of a hybrid micelle--hydrogel system for topical delivery of doxorubicin to skin cancer cells
The findings indicate that a hybrid micelle--hydrogel platform enables controlled delivery of DOX, enhancing topical efficacy in skin cancer while minimizing systemic exposure in a patient-compatible manner.
Majid Zia-Behbahani, Elahehnaz Parhizkar, M. Aghdaie et al.
· Iranian Journal of Basic Med... · 0 citations